| Year |
Citation |
Score |
| 2024 |
Zhang Q, Jiang L, Wang W, Huber AK, Valvo VM, Jungles KM, Holcomb EA, Pearson AN, The S, Wang Z, Parsels LA, Parsels JD, Wahl DR, Rao A, Sahai V, ... Lawrence TS, et al. Potentiating the radiation-induced type I interferon anti-tumoral immune response by ATM inhibition in pancreatic cancer. Jci Insight. PMID 38376927 DOI: 10.1172/jci.insight.168824 |
0.353 |
|
| 2023 |
Lawrence TS, Aryal M, Evans J, Cuneo K, Chang D, Schipper M, Zhang Y, Balter J, Haken RT, Cao Y. Does Vascular Collapse Occur after Treatment of Hepatocellular Cancer with Stereotactic Body Radiation Therapy? International Journal of Radiation Oncology, Biology, Physics. PMID 37414260 DOI: 10.1016/j.ijrobp.2023.06.078 |
0.353 |
|
| 2022 |
Mittal A, Nenwani M, Sarangi I, Achreja A, Lawrence TS, Nagrath D. Radiotherapy-induced metabolic hallmarks in the tumor microenvironment. Trends in Cancer. PMID 35750630 DOI: 10.1016/j.trecan.2022.05.005 |
0.316 |
|
| 2021 |
Parsels LA, Zhang Q, Karnak D, Parsels JD, Lam K, Willers H, Green MD, Rehemtulla A, Lawrence TS, Morgan MA. Translation of DNA damage response inhibitors as chemoradiation sensitizers from the laboratory to the clinic. International Journal of Radiation Oncology, Biology, Physics. PMID 34348175 DOI: 10.1016/j.ijrobp.2021.07.1708 |
0.309 |
|
| 2021 |
Willers H, Pan X, Borgeaud N, Korovina I, Koi L, Egan R, Greninger P, Rosenkranz A, Kung J, Liss AS, Parsels LA, Morgan MA, Lawrence TS, Lin SH, Hong TS, et al. Screening and Validation of Molecular Targeted Radiosensitizers. International Journal of Radiation Oncology, Biology, Physics. PMID 34343607 DOI: 10.1016/j.ijrobp.2021.07.1694 |
0.34 |
|
| 2020 |
Parsels LA, Engelke CG, Parsels J, Flanagan SA, Zhang Q, Tanska D, Wahl DR, Canman CE, Lawrence TS, Morgan MA. Combinatorial efficacy of olaparib with radiation and ATR inhibitor requires PARP1 protein in homologous recombination proficient pancreatic cancer. Molecular Cancer Therapeutics. PMID 33268569 DOI: 10.1158/1535-7163.MCT-20-0365 |
0.343 |
|
| 2020 |
Rivera-Báez L, Lohse I, Lin E, Raghavan S, Owen S, Harouaka R, Herman K, Mehta G, Lawrence TS, Morgan MA, Cuneo KC, Nagrath S. Expansion of Circulating Tumor Cells from Patients with Locally Advanced Pancreatic Cancer Enable Patient Derived Xenografts and Functional Studies for Personalized Medicine. Cancers. 12. PMID 32326109 DOI: 10.3390/Cancers12041011 |
0.312 |
|
| 2020 |
Chandler BC, Moubadder L, Ritter CL, Liu M, Cameron M, Wilder-Romans K, Zhang A, Pesch AM, Michmerhuizen AR, Hirsh N, Androsiglio M, Ward T, Olsen E, Niknafs YS, Merajver S, ... ... Lawrence TS, et al. TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination. The Journal of Clinical Investigation. PMID 31961339 DOI: 10.1172/Jci130435 |
0.311 |
|
| 2020 |
Chandler B, Moubadder L, Ritter C, Liu M, Cameron M, Wilder-Romans K, Zhang A, Pesch A, Michmerhuizen A, Hirsh N, Androsiglio M, Ward T, Olsen E, Niknafs Y, Merajver S, ... ... Lawrence T, et al. Abstract 6273: TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination Cancer Research. 80: 6273-6273. DOI: 10.1158/1538-7445.Am2020-6273 |
0.308 |
|
| 2019 |
Lang X, Green MD, Wang W, Yu J, Choi JE, Jiang L, Liao P, Zhou J, Zhang Q, Dow A, Saripalli AL, Kryczek I, Wei S, Szeliga W, Vatan L, ... ... Lawrence TS, et al. Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discovery. PMID 31554642 DOI: 10.1158/2159-8290.Cd-19-0338 |
0.359 |
|
| 2019 |
Cuneo KC, Morgan MA, Sahai V, Schipper MJ, Parsels LA, Parsels JD, Devasia T, Al-Hawaray M, Cho CS, Nathan H, Maybaum J, Zalupski MM, Lawrence TS. Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900730. PMID 31398082 DOI: 10.1200/Jco.19.00730 |
0.303 |
|
| 2019 |
Zhang Q, Green MD, Lang X, Lazarus J, Parsels J, Wei S, Parsels LA, Shi J, Ramnath N, Wahl DR, Pasca di Magliano M, Frankel TL, Kryczek I, Lei Y, Lawrence TS, et al. Inhibition of ATM increases interferon signaling and sensitizes pancreatic cancer to immune checkpoint blockade therapy. Cancer Research. PMID 31101760 DOI: 10.1158/0008-5472.Can-19-0761 |
0.367 |
|
| 2019 |
Kamarajah SK, Sonnenday CJ, Cho CS, Frankel TL, Bednar F, Lawrence TS, Nathan H. Association of Adjuvant Radiotherapy With Survival After Margin-negative Resection of Pancreatic Ductal Adenocarcinoma: A Propensity-matched National Cancer Database (NCDB) Analysis. Annals of Surgery. PMID 30817352 DOI: 10.1097/SLA.0000000000003242 |
0.304 |
|
| 2019 |
Cuneo KC, Morgan MA, Zalupski MM, Sahai V, Schipper MJ, Maybaum J, Lawrence TS. Abstract CT235: A dose escalation trial of the Wee1 inhibitor AZD1775, in combination with gemcitabine and radiation for patients with locally advanced pancreatic cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-Ct235 |
0.317 |
|
| 2019 |
Green M, Zhang Q, Lang X, Lei Y, Lawrence TS, Zou W, Morgan MA. Abstract B19: Targeting ATM to sensitize pancreatic cancer to immunotherapy and radiotherapy Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-B19 |
0.352 |
|
| 2017 |
Cuneo KC, Morgan M, Schipper MJ, Maybaum J, Al-Hawary M, Simeone DM, Sahai V, Zalupski M, Lawrence TS. Phase I study of definitive chemoradiation with gemcitabine and the WEE1 inhibitor AZD1775 in unresectable pancreatic cancer. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.4_Suppl.Tps512 |
0.341 |
|
| 2017 |
Cuneo K, Wang Y, Morgan M, Rivera L, Lohse I, Lawrence T, Nagrath S. Monitoring Circulating Tumor Cells during Chemoradiation Therapy for Locally Advanced Pancreatic Cancer International Journal of Radiation Oncology*Biology*Physics. 99: E585-E586. DOI: 10.1016/J.IJROBP.2017.06.2009 |
0.365 |
|
| 2016 |
Wahl DR, Dresser J, Wilder-Romans K, Parsels JD, Zhao SG, Davis M, Zhao L, Kachman M, Wernisch S, Burant CF, Morgan MA, Feng FY, Speers C, Lyssiotis CA, Lawrence TS. Glioblastoma therapy can be augmented by targeting IDH1-mediated NADPH biosynthesis. Cancer Research. PMID 27923831 DOI: 10.1158/0008-5472.Can-16-2008 |
0.307 |
|
| 2016 |
Cuneo KC, Morgan M, Schipper MJ, Maybaum J, Feng MU, Al-Hawary M, Simeone DM, Olson LD, Sahai V, Zalupski M, Lawrence TS. Abstract CT035: A dose escalation trial of the WEE1 inhibitor AZD1775, gemcitabine, and concurrent radiation in locally advanced pancreatic cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Ct035 |
0.368 |
|
| 2016 |
Parsels LA, Karnak D, Parsels JD, Reichert Z, Maybaum J, Lawrence TS, Morgan MA. Abstract 519: Combined inhibition of WEE1 and PARP1 radiosensitizes KRAS mutant non-small cell lung cancers via inhibition of DSB repair Cancer Research. 76: 519-519. DOI: 10.1158/1538-7445.Am2016-519 |
0.302 |
|
| 2015 |
Kausar T, Schreiber JS, Karnak D, Parsels LA, Parsels JD, Davis MA, Zhao L, Maybaum J, Lawrence TS, Morgan MA. Sensitization of Pancreatic Cancers to Gemcitabine Chemoradiation by WEE1 Kinase Inhibition Depends on Homologous Recombination Repair. Neoplasia (New York, N.Y.). 17: 757-66. PMID 26585231 DOI: 10.1016/J.Neo.2015.09.006 |
0.387 |
|
| 2015 |
Morgan MA, Lawrence TS. Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 2898-904. PMID 26133775 DOI: 10.1158/1078-0432.CCR-13-3229 |
0.308 |
|
| 2014 |
Karnak D, Engelke CG, Parsels LA, Kausar T, Wei D, Robertson JR, Marsh KB, Davis MA, Zhao L, Maybaum J, Lawrence TS, Morgan MA. Combined inhibition of Wee1 and PARP1/2 for radiosensitization in pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5085-96. PMID 25117293 DOI: 10.1158/1078-0432.Ccr-14-1038 |
0.361 |
|
| 2014 |
Wang H, Farjam R, Feng M, Hussain H, Ten Haken RK, Lawrence TS, Cao Y. Arterial perfusion imaging-defined subvolume of intrahepatic cancer. International Journal of Radiation Oncology, Biology, Physics. 89: 167-74. PMID 24613814 DOI: 10.1016/j.ijrobp.2014.01.040 |
0.326 |
|
| 2014 |
Kausar T, Parsels LA, Parsels JD, Karnak D, Davis MA, Maybaum J, Lawrence TS, Morgan MA. Abstract 862: Sensitization of pancreatic cancer to chemoradiation by the Wee1 inhibitor AZD1775 Cancer Research. 74: 862-862. DOI: 10.1158/1538-7445.Am2014-862 |
0.389 |
|
| 2013 |
Liu E, Stenmark MH, Schipper MJ, Balter JM, Kessler ML, Caoili EM, Lee OE, Ben-Josef E, Lawrence TS, Feng M. Stereotactic body radiation therapy for primary and metastatic liver tumors. Translational Oncology. 6: 442-6. PMID 23908687 DOI: 10.1593/Tlo.12448 |
0.301 |
|
| 2013 |
Engelke CG, Parsels LA, Qian Y, Zhang Q, Karnak D, Robertson JR, Tanska DM, Wei D, Davis MA, Parsels JD, Zhao L, Greenson JK, Lawrence TS, Maybaum J, Morgan MA. Sensitization of pancreatic cancer to chemoradiation by the Chk1 inhibitor MK8776. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 4412-21. PMID 23804422 DOI: 10.1158/1078-0432.Ccr-12-3748 |
0.412 |
|
| 2013 |
Kim EJ, Ben-Josef E, Herman JM, Bekaii-Saab T, Dawson LA, Griffith KA, Francis IR, Greenson JK, Simeone DM, Lawrence TS, Laheru D, Wolfgang CL, Williams T, Bloomston M, Moore MJ, et al. A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer. Cancer. 119: 2692-700. PMID 23720019 DOI: 10.1002/Cncr.28117 |
0.318 |
|
| 2013 |
Lin SH, George TJ, Ben-Josef E, Bradley J, Choe KS, Edelman MJ, Guha C, Krishnan S, Lawrence TS, Le QT, Lu B, Mehta M, Peereboom D, Sarkaria J, Seong J, et al. Opportunities and challenges in the era of molecularly targeted agents and radiation therapy. Journal of the National Cancer Institute. 105: 686-93. PMID 23503600 DOI: 10.1093/Jnci/Djt055 |
0.307 |
|
| 2013 |
Williams T, Galbán S, Li F, Heist K, Galbán C, Lawrence TS, Holland EC, Thomae T, Chenevert T, Rehemtulla A, Ross BD. Abstract 4433: DW-MR imaging as a predictive biomarker of radiosensitization of GBM through targeted inhibition of checkpoint kinases. Cancer Research. 73: 4433-4433. DOI: 10.1158/1538-7445.Am2013-4433 |
0.361 |
|
| 2013 |
Wei D, Parsels LA, Davis MA, Zhao L, Maybaum J, Lawrence TS, Sun Y, Morgan MA. Abstract 1582: Inhibition of protein phosphatase 2A radiosensitizes pancreatic cancer cells by modulation of CDC25C. Cancer Research. 73: 1582-1582. DOI: 10.1158/1538-7445.Am2013-1582 |
0.411 |
|
| 2012 |
Venkatesha VA, Parsels LA, Parsels JD, Zhao L, Zabludoff SD, Simeone DM, Maybaum J, Lawrence TS, Morgan MA. Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition. Neoplasia (New York, N.Y.). 14: 519-25. PMID 22787433 DOI: 10.1593/Neo.12538 |
0.382 |
|
| 2012 |
Feng M, Smith DE, Normolle DP, Knol JA, Pan CC, Ben-Josef E, Lu Z, Feng MR, Chen J, Ensminger W, Lawrence TS. A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 83: 1441-7. PMID 22440042 DOI: 10.1016/j.ijrobp.2011.10.020 |
0.303 |
|
| 2012 |
Williams TM, Flecha AR, Keller P, Ram A, Karnak D, Galbán S, Galbán CJ, Ross BD, Lawrence TS, Rehemtulla A, Sebolt-Leopold J. Cotargeting MAPK and PI3K signaling with concurrent radiotherapy as a strategy for the treatment of pancreatic cancer. Molecular Cancer Therapeutics. 11: 1193-202. PMID 22411900 DOI: 10.1158/1535-7163.Mct-12-0098 |
0.384 |
|
| 2012 |
Wei D, Li H, Yu J, Sebolt JT, Zhao L, Lawrence TS, Smith PG, Morgan MA, Sun Y. Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor. Cancer Research. 72: 282-93. PMID 22072567 DOI: 10.1158/0008-5472.Can-11-2866 |
0.316 |
|
| 2012 |
Williams TM, Flecha A, Keller P, Ram A, Karnak D, Ross B, Lawrence T, Rehemtulla A, Sebolt-Leopold J. Abstract B43: Co-targeting MAPK and PI3K signaling with concurrent radiotherapy as a strategy for the treatment of pancreatic cancer. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-B43 |
0.393 |
|
| 2012 |
Wang L, Lawrence T, Xu L, Canman C, Ljungman M, Simeone D, Yang H, Palmbos P, Ney G, Detzler TA, Coleman D, Davis M, Hicks K, Helchowski CM. Abstract A93: Radiation-induced phosphorylation of ATDC via ATM/MAPKAP kinase 2 signaling mediates radioresistance of pancreatic cancer cells. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-A93 |
0.397 |
|
| 2012 |
Karnak D, Parsels LA, Maybaum J, Lawrence TS, Morgan MA. Abstract 1459: Combined inhibition of Wee1 and PARP1 sensitizes pancreatic cancer cells to radiation Cancer Research. 72: 1459-1459. DOI: 10.1158/1538-7445.Am2012-1459 |
0.319 |
|
| 2011 |
Dai Y, Desano J, Qu Y, Tang W, Meng Y, Lawrence TS, Xu L. Natural IAP inhibitor Embelin enhances therapeutic efficacy of ionizing radiation in prostate cancer. American Journal of Cancer Research. 1: 128-43. PMID 21804946 |
0.374 |
|
| 2011 |
Zielske SP, Spalding AC, Wicha MS, Lawrence TS. Ablation of breast cancer stem cells with radiation. Translational Oncology. 4: 227-33. PMID 21804918 DOI: 10.1593/Tlo.10247 |
0.696 |
|
| 2011 |
Parsels LA, Qian Y, Tanska DM, Gross M, Zhao L, Hassan MC, Arumugarajah S, Parsels JD, Hylander-Gans L, Simeone DM, Morosini D, Brown JL, Zabludoff SD, Maybaum J, Lawrence TS, et al. Assessment of chk1 phosphorylation as a pharmacodynamic biomarker of chk1 inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 3706-15. PMID 21482692 DOI: 10.1158/1078-0432.Ccr-10-3082 |
0.348 |
|
| 2011 |
Venkatesha VA, Parsels LA, Parsels JD, Zabludoff SD, Maybaum J, Lawrence TS, Morgan MA. Abstract 3919: Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition Cancer Research. 71: 3919-3919. DOI: 10.1158/1538-7445.Am2011-3919 |
0.348 |
|
| 2010 |
Zielske SP, Spalding AC, Lawrence TS. Loss of tumor-initiating cell activity in cyclophosphamide-treated breast xenografts. Translational Oncology. 3: 149-52. PMID 20563255 DOI: 10.1593/Tlo.09307 |
0.678 |
|
| 2010 |
Watson RL, Spalding AC, Zielske SP, Morgan M, Kim AC, Bommer GT, Eldar-Finkelman H, Giordano T, Fearon ER, Hammer GD, Lawrence TS, Ben-Josef E. GSK3beta and beta-catenin modulate radiation cytotoxicity in pancreatic cancer. Neoplasia (New York, N.Y.). 12: 357-65. PMID 20454507 DOI: 10.1593/Neo.92112 |
0.647 |
|
| 2010 |
Morgan MA, Parsels L, Zhao L, Parsels J, Davis M, Arumugarajah S, Canman C, Zabludoff S, Maybaum J, Lawrence T. Abstract 491: The roles of homologous recombination repair and cell cycle checkpoints in radiosensitization by the Chk1/2 inhibitor, AZD7762 Cancer Research. 70: 491-491. DOI: 10.1158/1538-7445.Am10-491 |
0.32 |
|
| 2010 |
Parsels LA, Morgan MA, Tanska DM, Parsels JD, Davis MA, Hassan MC, Arumugarajah S, Hylander-Gans L, Morosini D, Zhao L, Simeone DM, Canman CE, Normolle DP, Zabludoff SD, Lawrence TS, et al. Abstract 1765: Preclinical optimization of the Chk1/2 inhibitor AZD7762 in combination with gemcitabine in pancreatic cancer Cancer Research. 70: 1765-1765. DOI: 10.1158/1538-7445.Am10-1765 |
0.351 |
|
| 2010 |
Karnak D, Dai Y, DeSano JT, Tang W, Ljungman M, Lawrence TS, Xu L. Abstract 1394: Pro-apoptotic and anti-tumorigenic effects of a naturally occurring proteasome inhibitor on hormone-refractory prostate cancer Cancer Research. 70: 1394-1394. DOI: 10.1158/1538-7445.Am10-1394 |
0.301 |
|
| 2009 |
Zielske SP, Livant DL, Lawrence TS. Radiation increases invasion of gene-modified mesenchymal stem cells into tumors. International Journal of Radiation Oncology, Biology, Physics. 75: 843-53. PMID 18849123 DOI: 10.1016/J.Ijrobp.2008.06.1953 |
0.69 |
|
| 2009 |
Xu L, Ji Q, Hao X, Tang W, Li L, DeSano JT, Fearon ER, Lawrence TS. Abstract A53: Tumor suppressor microRNA miR‐34 inhibits human pancreatic and gastric cancer stem cells Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-A53 |
0.32 |
|
| 2008 |
Spalding AC, Zeitlin BD, Wilder-Romans K, Davis ME, Nor JE, Lawrence TS, Ben-Josef E. Enzastaurin, an inhibitor of PKCbeta, Enhances Antiangiogenic Effects and Cytotoxicity of Radiation against Endothelial Cells. Translational Oncology. 1: 195-201. PMID 19043530 DOI: 10.1593/Tlo.08151 |
0.345 |
|
| 2008 |
Morgan MA, Meirovitz A, Davis MA, Kollar LE, Hassan MC, Lawrence TS. Radiotherapy combined with gemcitabine and oxaliplatin in pancreatic cancer cells. Translational Oncology. 1: 36-43. PMID 18607506 DOI: 10.1593/TLO.07106 |
0.359 |
|
| 2008 |
Abela RA, Qian J, Xu L, Lawrence TS, Zhang M. Radiation improves gene delivery by a novel transferrin-lipoplex nanoparticle selectively in cancer cells. Cancer Gene Therapy. 15: 496-507. PMID 18483503 DOI: 10.1038/cgt.2008.26 |
0.371 |
|
| 2008 |
Contessa JN, Bhojani MS, Freeze HH, Rehemtulla A, Lawrence TS. Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells. Cancer Research. 68: 3803-9. PMID 18483264 DOI: 10.1158/0008-5472.CAN-07-6389 |
0.303 |
|
| 2008 |
Wang L, Piert M, Zhao L, Lawrence T, Kong F. PET Study Demonstrates Radiation Dependent Changes on Tumor Hypoxia and Proliferation during the Course of Radiotherapy in a Lung Cancer Xenograft Model International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.833 |
0.344 |
|
| 2007 |
Spalding AC, Watson R, Davis ME, Kim AC, Lawrence TS, Ben-Josef E. Inhibition of protein kinase Cbeta by enzastaurin enhances radiation cytotoxicity in pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 6827-33. PMID 18006785 DOI: 10.1158/1078-0432.Ccr-07-0454 |
0.389 |
|
| 2007 |
Spalding A, Watson R, Zielske S, Kim A, Bommer G, Fearon E, Eldar-Finkelman H, Lawrence T, Ben-Josef E. Glycogen Synthase Kinase 3β Inhibition and βcatenin Activation Contribute to Enhanced Survival After Radiation in Pancreatic Cancer Cells International Journal of Radiation Oncology*Biology*Physics. 69: S608. DOI: 10.1016/J.Ijrobp.2007.07.1918 |
0.663 |
|
| 2006 |
Nyati MK, Feng FY, Maheshwari D, Varambally S, Zielske SP, Ahsan A, Chun PY, Arora VA, Davis MA, Jung M, Ljungman M, Canman CE, Chinnaiyan AM, Lawrence TS. Ataxia telangiectasia mutated down-regulates phospho-extracellular signal-regulated kinase 1/2 via activation of MKP-1 in response to radiation. Cancer Research. 66: 11554-9. PMID 17178844 DOI: 10.1158/0008-5472.Can-06-1935 |
0.632 |
|
| 2006 |
Ray ME, Lawrence TS. Radiation therapy for aggressive fibromatosis (desmoid tumor). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 3714-5; author reply. PMID 16877745 DOI: 10.1200/JCO.2006.06.7306 |
0.345 |
|
| 2006 |
Huang XW, Yang J, Dragovic AF, Zhang H, Lawrence TS, Zhang M. Antisense oligonucleotide inhibition of tumor necrosis factor receptor 1 protects the liver from radiation-induced apoptosis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 2849-55. PMID 16675580 DOI: 10.1158/1078-0432.CCR-06-0360 |
0.304 |
|
| 2006 |
kong f, Frey K, Gross M, Feng M, Fernando S, Kessler M, Chetty I, Ten Haken R, McShan D, Normolle D, Tatro D, Hayman J, Kalemkerian G, Lawrence T, Eisbruch A. SU-FF-J-34: Can Functional Imaging Be Used to Individualize Adaptive Radiation Therapy for Non-Small Cell Lung Cancer? Medical Physics. 33: 2027-2028. DOI: 10.1118/1.2240812 |
0.329 |
|
| 2006 |
Zielske SP, Lawrence TS. 952. Human Mesenchymal Stem Cells Migrate to Colon Cancer Xenografts: Potential Carriers of Cancer Therapeutics Molecular Therapy. 13: S367. DOI: 10.1016/J.Ymthe.2006.08.1044 |
0.679 |
|
| 2005 |
Qian J, Yang J, Dragovic AF, Abu-Isa E, Lawrence TS, Zhang M. Ionizing radiation-induced adenovirus infection is mediated by Dynamin 2. Cancer Research. 65: 5493-7. PMID 15994918 DOI: 10.1158/0008-5472.CAN-04-4526 |
0.383 |
|
| 2005 |
Xu L, Yang D, Wang S, Tang W, Liu M, Davis M, Chen J, Rae JM, Lawrence T, Lippman ME. (-)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer. Molecular Cancer Therapeutics. 4: 197-205. PMID 15713891 |
0.357 |
|
| 2005 |
Huang XW, Tang ZY, Lawrence TS, Zhang M. 5-fluorouracil and hydroxyurea enhance adenovirus-mediated transgene expression in colon and hepatocellular carcinoma cells. Journal of Cancer Research and Clinical Oncology. 131: 184-90. PMID 15538627 DOI: 10.1007/s00432-004-0608-1 |
0.316 |
|
| 2004 |
Dawson LA, Lawrence TS. The role of radiotherapy in the treatment of liver metastases. Cancer Journal (Sudbury, Mass.). 10: 139-44. PMID 15130273 DOI: 10.1097/00130404-200403000-00009 |
0.304 |
|
| 2003 |
Lawrence TS. Radiation sensitizers and targeted therapies Oncology (Williston Park, N.Y.). 17: 23-28. PMID 14723003 |
0.338 |
|
| 2003 |
Dawson LA, McGinn CJ, Lawrence TS. Conformal Chemoradiation for Primary and Metastatic Liver Malignancies Seminars in Surgical Oncology. 21: 249-255. PMID 14648782 DOI: 10.1002/ssu.10043 |
0.342 |
|
| 2003 |
Zhang M, Li S, Li J, Ensminger WD, Lawrence TS. Ionizing radiation increases adenovirus uptake and improves transgene expression in intrahepatic colon cancer xenografts. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 21-8. PMID 12842425 DOI: 10.1016/S1525-0016(03)00143-6 |
0.366 |
|
| 2003 |
Lawrence TS, Blackstock AW, McGinn C. The mechanism of action of radiosensitization of conventional chemotherapeutic agents Seminars in Radiation Oncology. 13: 13-21. PMID 12520460 DOI: 10.1053/srao.2003.50002 |
0.337 |
|
| 2003 |
Binkley CE, Davis MA, Zhang L, Lawrence TS, Logsdon CD, Simeone DM. The ataxia telangiectasia group D associated gene confers a cellular survival advantage in pancreatic adenocarcinoma Journal of Surgical Research. 114: 240. DOI: 10.1016/J.Jss.2003.08.131 |
0.332 |
|
| 2002 |
Nyati M, Symon Z, Kievit E, Dornfeld K, Rynkiewicz S, Ross B, Rehemtulla A, Lawrence T. The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model. Gene Therapy. 9: 844-849. PMID 12080378 DOI: 10.1038/Sj.Gt.3301706 |
0.445 |
|
| 2000 |
Fields MT, Eisbruch A, Normolle D, Orfali A, Davis MA, Pu AT, Lawrence TS. Radiosensitization produced in vivo by once- vs. twice-weekly 2'2'-difluoro-2'-deoxycytidine (gemcitabine). International Journal of Radiation Oncology, Biology, Physics. 47: 785-91. PMID 10837965 DOI: 10.1016/S0360-3016(00)00447-8 |
0.344 |
|
| 1997 |
Shewach DS, Lawrence TS. Gemcitabine and radiosensitization in human tumor cells. Investigational New Drugs. 14: 257-63. PMID 8958180 DOI: 10.1007/Bf00194528 |
0.374 |
|
| Show low-probability matches. |